Lung Cancer News
- Despite Skeptics, At-Home Chemo Programs Continue Growing
- Alert FDA Approves Cemiplimab-rwlc for NSCLC With PD-L1 Expression
- Cancer Death Rates Continue to Fall in Europe, Except For...
- EU Sues More Countries Over Air Pollution, Nature and Water
- Rush Limbaugh Dies at 70 Following Lung Cancer Diagnosis
- Cancer Warning Labels on Alcohol: Calls for Congress to Act
- Alert First Drug That Protects Against Chemo-Induced Myelosuppression
- Nearly 4 in 10 Cancer Deaths Attributable to Cigarette Smoking
- ASCO Endorses Guidelines on Radiation Therapy for SCLC
- WCLC 2020 Amivantamab Shows Promise in Challenging EGFR-Mutated NSCLC
- WCLC 2020 Neoadjuvant Atezolizumab Safe in Resectable Lung Cancer
- WCLC 2020 Customized Chemotherapy Did Not Improve Survival in Early NSCLC
- WCLC 2020 Combo Immunotherapy in NSCLC: Not These Two Drugs
- Beyond COVID-19: Can mRNA Treat Diseases, Too?
- 'We Can Do Better': COVID-19 Vaccination in Cancer Patients
- WCLC 2020 'Unprecedented' Long-term Survival After IO in Pretreated NSCLC
- WCLC 2020 Sotorasib in NSCLC: 'Historic Milestone' Reached
- Alert FDA Grants MET Inhibitor Tepotinib Accelerated Approval for NSCLC
- Breast Cancer Overtakes Lung as Most Common Cancer: WHO
- WCLC 2020 COVID Has Led to a Drop in Lung Cancer Diagnosis, More Deaths